Jinsong Ni

This inventor holds 23 USPTO granted patents and 15 published patent applications and 7 EPO patents, primarily in Ophthalmic Treatments. Top assignees: Ads Therapeutics LLC, Cloudbreak Therapeutics LLC. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jinsong Ni. Retrieved from https://idiyas.com/inventor/jinsong-ni

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 23 (Patent Applications = 15)

% Patents Active = 95.7

EPO Patents = 7 (Patent Applications = 20)

Average Co-Inventor Count = 1.7

ph-index = 5

Forward Citations = 78(Granted Patents)

Company Filing History:

Cloudbreak Therapeutics LLC

patents

Years Active: 2018-2026

Loading Chart...

Areas of Expertise:

Alpha2 Adrenergic Agonist

Muscarinic Agonist

Nintedanib

Ocular Diseases

Anti-Angiogenic

VEGF Conjugates

Pterygium Recurrence

Topical Compositions

Meibomian Gland Dysfunction

Hyperemia

Rosacea Treatments

Emulsion Formulations

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12622893 - Alpha2 adrenergic agonist codrugs conjugated with muscarinic agonist drugs (2026-05-12),

2. 12491183 - Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization (2025-12-09),

3. 12485177 - Topical ophthalmological compositions (2025-12-02),

4. 12214049 - Anti-angiogenic antibody-drug conjugates (2025-02-04),

5. 12186424 - Compositions and methods for treating pterygium recurrence (2025-01-07),

6. 12156873 - Composition for treating ocular hyperemia and a method for treating ocular hyperemia with the same (2024-12-03),

7. 12070501 - Topical ophthalmological compositions (2024-08-27),

8. 11911379 - Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization (2024-02-27),

9. 11666533 - Emulsion formulations of multikinase inhibitors (2023-06-06),

10. 11246864 - Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization (2022-02-15),

11. 11191751 - Topical ophthalmological atropine free base compositions (2021-12-07),

12. 11179388 - Topical composition for treating rosacea and a method for treating rosacea with the same (2021-11-23),

13. 11166977 - Compositions for treating meibomian gland dysfunction (2021-11-09),

14. 11007214 - Compositions and methods for treating eye diseases (2021-05-18),

15. 10980741 - Compositions and methods for treating pterygium recurrence (2021-04-20),

Title: The Innovative Journey of Jinsong Ni

Introduction: Jinsong Ni, a talented inventor based in Irvine, CA, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Jinsong Ni holds several patents in the areas of renewable energy, sustainable materials, and advanced electronics, showcasing his diverse range of expertise.

Career Highlights: With a background in engineering and a passion for creating solutions to complex problems, Jinsong Ni has successfully brought several inventions from concept to market, revolutionizing industries along the way.

Collaborations: Throughout his career, Jinsong Ni has collaborated with leading research institutions, universities, and tech companies to further develop his inventions and bring them to the forefront of technological advancements.

Conclusion: Jinsong Ni's dedication to innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.